Sickle cell anemia – non-invasive prenatal screening of pregnant women

Sickle cell anemia It is a congenital hemoglobinopathy that develops as a result of a mutation in the gene that synthesizes the beta chain of hemoglobin and causes the deformation of erythrocytes. Erythrocytes are easily broken, which is followed by the development of anemia.


Learn more about sickle cell disease:



VERAgene is a new generation non-invasive prenatal test that accurately detects the risk of the fetus developing common chromosomal abnormalities. In addition to standard aneuploidies and microdeletions, VERAgene studies 2,000 mutations and detects 100 monogenic diseases.


Find out more and book online:




👁Follow our social pages and learn more
Call Now Button